Reassessing rare cancers
نویسندگان
چکیده
منابع مشابه
International Rare Cancers Initiative (IRCI)
There is no internationally agreed definition of a rare cancer. In Europe, rare diseases are often defined as those with a prevalence of <50/100,000 [1]. In the US, the Orphan Drug Designation Program defines rare diseases as those affecting <200,000 people in the total US population, equivalent to a prevalence of 64/100,000 [1]. The problem with both these definitions is that they are based on...
متن کاملThe burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
AIMS AND BACKGROUND The project Surveillance of rare cancers in Italy (RITA) provides, for the first time, estimates of the burden of rare cancers in Italy based on the list of rare cancers proposed in collaboration with the European project Surveillance of Rare Cancers in Europe (RARECARE). METHODS RITA analyzed data from Italian population-based cancer registries (CR). The period of diagnos...
متن کاملMendelian genetics of rare--and not so rare--cancers.
Mendelian genetics forms the basis for gene-informed risk assessment and management for the patient and family, and should be at the very foundation of 21st century personalization of healthcare. Yet this is an underutilized commodity. Identification and characterization of germline mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, as causing >90% of multiple endocrine n...
متن کاملDeveloping treatment strategies for rare cancers
Trial therapies for rare cancers are usually selected empirically and often fail during clinical testing. The poor efficiency and limited success of this process is hampered by a lack of accurate models with which to perform preclinical studies, and small patient numbers that are likely to include distinct subtypes. These challenges are further compounded by increasing evidence that many cancer...
متن کاملRare thoracic cancers, including peritoneum mesothelioma.
Rare thoracic cancers include those of the trachea, thymus and mesothelioma (including peritoneum mesothelioma). The aim of this study was to describe the incidence, prevalence and survival of rare thoracic tumours using a large database, which includes cancer patients diagnosed from 1978 to 2002, registered in 89 population-based cancer registries (CRs) and followed-up to 31st December 2003. O...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Journal of Australia
سال: 2015
ISSN: 0025-729X,1326-5377
DOI: 10.5694/mja15.00974